Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Measuring Competency of Pharmacy Residents: A Survey of Residency Programs' Methods for Assessment and Evaluation.

Kary SJ, Dumont Z, Tangedal K, Bolt J, Semchuk WM.

Can J Hosp Pharm. 2019 Sep-Oct;72(5):343-352. Epub 2019 Oct 21.

2.

Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs.

Lamb DA, Bungard TJ, Lowerison J, Semchuk WM, Thomson P, Brocklebank C, Bolt J.

Ann Pharmacother. 2020 Mar;54(3):277-282. doi: 10.1177/1060028019877215. Epub 2019 Sep 17.

PMID:
31529984
3.

Departmental Initiative to Improve Documentation in the Medical Record by Acute Care Pharmacists.

Zimmer S, Gray C, Roy C, Semchuk WM.

Can J Hosp Pharm. 2019 Mar-Apr;72(2):151-154. Epub 2018 Apr 30. No abstract available.

4.

Transient Ischemic Attack in a High-Risk Cardiovascular Patient with Renal Dysfunction after Treatment with Rivaroxaban and Clopidogrel: A Case Report.

Kary SJ, Roy CJ, Semchuk WM, Lavoie AJ.

Can J Hosp Pharm. 2019 Jan-Feb;72(1):49-51. Epub 2018 Feb 28. No abstract available.

5.

Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals.

Bungard TJ, Ritchie B, Bolt J, Semchuk WM.

BMJ Open. 2018 Oct 31;8(10):e022065. doi: 10.1136/bmjopen-2018-022065.

6.

Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department.

Bungard TJ, Ritchie B, Bolt J, Semchuk WM.

BMJ Open. 2018 Oct 31;8(10):e022064. doi: 10.1136/bmjopen-2018-022064.

7.
8.

Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran.

Weitz JI, Earl KM, Leblanc K, Semchuk W, Jamali F.

Can J Cardiol. 2018 Sep;34(9):1116-1119. doi: 10.1016/j.cjca.2018.05.023. Epub 2018 Jun 5.

PMID:
30093297
9.

Pharmacists' Roles in Critical Care: Environmental Scan of Current Practices in Canadian Intensive Care Units.

Mailman JF, Semchuk W.

Can J Hosp Pharm. 2018 May-Jun;71(3):215-216. Epub 2018 Jun 28. No abstract available.

10.

Pharmacists' assessment and management of acute and chronic gout.

Haines A, Bolt J, Dumont Z, Semchuk W.

Can Pharm J (Ott). 2018 Feb 9;151(2):107-113. doi: 10.1177/1715163518754916. eCollection 2018 Mar-Apr. No abstract available.

11.

A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Leblanc K, Semchuk WM, Papastergiou J, Snow B, Mandlsohn L, Kapoor V, Guirguis LM, Douketis JD, Geerts W, Gladstone DJ.

Can Pharm J (Ott). 2018 Feb 9;151(2):102-106. doi: 10.1177/1715163518756926. eCollection 2018 Mar-Apr. No abstract available.

12.

Development of a Documentation Rubric and Assessment of Pharmacists' Competency for Documentation in the Patient Health Record.

Baranski B, Bolt J, Albers L, Siddiqui R, Bell A, Semchuk W.

Can J Hosp Pharm. 2017 Nov-Dec;70(6):423-429. Epub 2017 Dec 21.

13.

Ensuring Accurate, Timely Medication Orders and Reducing Errors: Assessment of a Read-Back Tactic.

Mailman JF, Betcher J, Semchuk W.

Can J Hosp Pharm. 2017 Sep-Oct;70(5):395-396. Epub 2017 Oct 31. No abstract available.

14.

The management of venous thromboembolism: A practical tool for the front-line clinician.

Bungard TJ, Semchuk W.

Can Pharm J (Ott). 2017 Feb 9;150(2):81-89. doi: 10.1177/1715163517691062. eCollection 2017 Mar-Apr. No abstract available.

15.

Development of Left Atrial Thrombus After Coadministration of Dabigatran Etexilate and Phenytoin.

Hager N, Bolt J, Albers L, Wojcik W, Duffy P, Semchuk W.

Can J Cardiol. 2017 Apr;33(4):554.e13-554.e14. doi: 10.1016/j.cjca.2016.10.022. Epub 2016 Oct 28.

PMID:
28063739
16.

How Should Canadian Pharmacy Departments Utilize Idarucizumab?

Tangedal K, Semchuk W, Bolt J.

Can J Hosp Pharm. 2016 Sep-Oct;69(5):429-430. Epub 2016 Oct 31. No abstract available.

17.

Inhaler assessment in COPD patients: A primer for pharmacists.

Dougall S, Bolt J, Semchuk W, Winkel T.

Can Pharm J (Ott). 2016 Sep;149(5):268-273. Epub 2016 Jul 27. No abstract available.

18.

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Blackburn DF, Evans CD, Eurich DT, Mansell KD, Jorgenson DJ, Taylor JG, Semchuk WM, Shevchuk YM, Remillard AJ, Tran DA, Champagne AP.

Pharmacotherapy. 2016 Oct;36(10):1055-1064. doi: 10.1002/phar.1831. Epub 2016 Sep 25.

PMID:
27581815
19.

Measurement of Clinical Pharmacy Key Performance Indicators to Focus and Improve Your Hospital Pharmacy Practice.

Lo E, Rainkie D, Semchuk WM, Gorman SK, Toombs K, Slavik RS, Forbes D, Meade A, Fernandes O, Spina SP.

Can J Hosp Pharm. 2016 Mar-Apr;69(2):149-55. Epub 2016 Apr 29. No abstract available.

20.

Assessment of Preceptor Development Strategies across Canadian Pharmacy Residency Programs.

Bolt J, Baranski B, Bell A, Semchuk WM.

Can J Hosp Pharm. 2016 Mar-Apr;69(2):144-8. Epub 2016 Apr 29. No abstract available.

21.

Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.

Weitz JI, Semchuk W, Turpie AG, Fisher WD, Kong C, Ciaccia A, Cairns JA.

Clin Ther. 2015 Nov 1;37(11):2506-2514.e4. doi: 10.1016/j.clinthera.2015.09.008. Epub 2015 Oct 16.

22.

Checklists for the use of novel oral anticoagulants by the front-line clinician.

Bungard TJ, Bolt J, Thomson P, Semchuk W, Lowerison J.

Can Pharm J (Ott). 2015 Sep;148(5):241-5. doi: 10.1177/1715163515596758. No abstract available.

23.

A Canadian Survey of Pharmacist Participation during Cardiopulmonary Resuscitation.

Bolt J, Semchuk W, Loewen P, Bell A, Strugari C.

Can J Hosp Pharm. 2015 Jul-Aug;68(4):290-5.

24.

A pharmacist's guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.

Ackman ML, Bucci C, Callaghan M, Kertland H, Pharand C, Robertson P, Semchuk W.

Can Pharm J (Ott). 2015 Mar;148(2):71-81. doi: 10.1177/1715163515569572. No abstract available.

25.

Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach.

Fernandes O, Gorman SK, Slavik RS, Semchuk WM, Shalansky S, Bussières JF, Doucette D, Bannerman H, Lo J, Shukla S, Chan WW, Benninger N, MacKinnon NJ, Bell CM, Slobodan J, Lyder C, Zed PJ, Toombs K.

Ann Pharmacother. 2015 Jun;49(6):656-69. doi: 10.1177/1060028015577445. Epub 2015 Mar 16.

PMID:
25780250
26.

Stability of Dabigatran Etexilate in Manufacturer's Blister Pack, Unit-Dose Packaging, and Community Pharmacy Blister Pack.

Wang EH, Bolt JL, Décarie D, Semchuk W, Ensom MH.

Can J Hosp Pharm. 2015 Jan-Feb;68(1):16-21.

27.

Southern Saskatchewan Ticagrelor Registry experience.

Dehghani P, Chopra V, Bell A, Kelly S, Zulyniak L, Booker J, Zimmermann R, Semchuk W, Cheema AN, Lavoie AJ.

Patient Prefer Adherence. 2014 Oct 16;8:1427-35. doi: 10.2147/PPA.S68423. eCollection 2014.

28.

Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke.

Semchuk WM, Levac B, Lara M, Shakespeare A, Evers T, Bolt J.

Can J Hosp Pharm. 2013 Sep;66(5):296-303.

29.

Medication adherence and beyond: Blood pressure control and the pharmacist.

Thompson A, Semchuk W.

Can Pharm J (Ott). 2012 Mar;145(2):66-67.e1. doi: 10.3821/145.2.cpj66. No abstract available.

30.

Prevention and treatment of venous thromboembolism in patients with cancer.

Semchuk WM, Sperlich C.

Can Pharm J (Ott). 2012 Jan;145(1):24-29.e1. doi: 10.3821/1913-701X-145.1.24.

31.

Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.

Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):228-35. doi: 10.1161/CIRCOUTCOMES.108.813600. Epub 2009 Apr 28.

PMID:
20031842
32.
33.

Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.

Evans CD, Eurich DT, Lamb DA, Taylor JG, Jorgenson DJ, Semchuk WM, Mansell KD, Blackburn DF.

J Manag Care Pharm. 2009 Jul-Aug;15(6):476-84.

34.

Tackling the burden of hypertension in Canada: encouraging collaborative care.

Thompson A, Campbell NR, Cloutier L, Costello JA, Dawes M, Hickey J, Kaczorowski J, Lewanczuk RZ, Semchuk W, Tsuyuki RT; Canadian Hypertension Education Program Implementation Task Force.

Can Fam Physician. 2008 Dec;54(12):1659-62, 1664-7. Review. English, French. No abstract available.

35.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
36.

A multicenter disease management program for hospitalized patients with heart failure.

Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, Kornder J, Mackay E, Manyari D, O'Reilly K, Semchuk W.

J Card Fail. 2004 Dec;10(6):473-80.

PMID:
15599837
37.

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Taylor JG.

Arch Intern Med. 2002 May 27;162(10):1149-55.

PMID:
12020186
38.

Practice-based research: lessons from community pharmacist participants.

Simpson SH, Johnson JA, Biggs C, Biggs RS, Kuntz A, Semchuk W, Taylor JG, Farris KB, Tsuyuki RT; Study of Cardiovascular Risk Intervention by Pharmacist Investigators.

Pharmacotherapy. 2001 Jun;21(6):731-9.

PMID:
11401185
39.

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.

Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Simpson SH, Taylor JG.

Ann Pharmacother. 1999 Sep;33(9):910-9.

PMID:
10492489
40.

Ketoconazole in the prevention of acute respiratory distress syndrome.

DeVries A, Semchuk WM, Betcher JG.

Pharmacotherapy. 1998 May-Jun;18(3):581-7. Review.

PMID:
9620108
41.

Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates.

Semchuk W, Shevchuk YM, Sankaran K, Wallace SM.

Biol Neonate. 1995;67(1):13-20.

PMID:
7748969
42.

Determination of a gentamicin loading dose in neonates and infants.

Semchuk W, Borgmann J, Bowman L.

Ther Drug Monit. 1993 Feb;15(1):47-51.

PMID:
8451781

Supplemental Content

Loading ...
Support Center